FTC Taking A Closer Look At $63B AbbVie-Allergan Deal
The Federal Trade Commission is seeking more details on the planned $63 billion merger of AbbVie and Allergan, a move both pharmaceutical companies called "expected" as they assured investors the deal is...To view the full article, register now.
Already a subscriber? Click here to view full article